T. Rowe Price Associates’s Costamare CMRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$527K Buy
37,528
+3,805
+11% +$62.4K ﹤0.01% 2604
2026
Q1
$570K Buy
33,723
+7,333
+28% +$122K ﹤0.01% 2390
2025
Q4
$417K Buy
26,390
+2,958
+13% +$40.9K ﹤0.01% 2475
2025
Q3
$280K Buy
23,432
+2,836
+14% +$31K ﹤0.01% 2631
2025
Q2
$188K Buy
20,596
+1,497
+8% +$13.3K ﹤0.01% 2734
2025
Q1
$188K Buy
19,099
+2,000
+12% +$22.1K ﹤0.01% 2667
2024
Q4
$220K Buy
17,099
+3,014
+21% +$41.5K ﹤0.01% 2638
2024
Q3
$222K Buy
14,085
+463
+3% +$6.67K ﹤0.01% 2611
2024
Q2
$224K Sell
13,622
-59
-0.4% -$806 ﹤0.01% 2549
2024
Q1
$156K Buy
13,681
+2,223
+19% +$24.6K ﹤0.01% 2689
2023
Q4
$120K Hold
11,458
﹤0.01% 2685
2023
Q3
$111K Buy
11,458
+547
+5% +$5.57K ﹤0.01% 2641
2023
Q2
$106K Buy
10,911
+843
+8% +$7.55K ﹤0.01% 2690
2023
Q1
$95K Buy
+10,068
New +$99.3K ﹤0.01% 2697

Other funds holding CMRE

T. Rowe Price Associates's CMRE Position: Q2 2026 in Review

T. Rowe Price Associates increased its Costamare (CMRE) stake by 11% in Q2 2026, buying an estimated $62.4K and bringing the position to 37,528 shares worth $527K. The position accounts for ﹤0.01% of the portfolio, ranked #2604.

T. Rowe Price Associates first reported a position in CMRE in Q1 2023 and has held it in 14 quarters since. The position peaked at $570K in Q1 2026. 195 funds tracked by Wall St. Rank hold CMRE as of Q2 2026.

  • T. Rowe Price Associates held 37,528 shares of Costamare worth $527K as of Q2 2026.
  • T. Rowe Price Associates bought 3,805 Costamare shares in Q2 2026, an estimated $62.4K.
  • Costamare made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2604 holding.
  • T. Rowe Price Associates first reported a position in Costamare in Q1 2023 and has held it in 14 quarters since.
  • T. Rowe Price Associates's Costamare position peaked at $570K in Q1 2026.
  • 195 funds tracked by Wall St. Rank held Costamare as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.